You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD122

Showing 1 - 25 of 939
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 9, 2023

Metastatic Melanoma Trial in Duarte, Portland, Philadelphia (Bempegaldesleukin (NKTR-214), Nivolumab, 8?Zr-Df-IAB22M2C)

Withdrawn
  • Metastatic Melanoma
  • Bempegaldesleukin (NKTR-214)
  • +2 more
  • Duarte, California
  • +2 more
Jun 28, 2021

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles

Not yet recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • Biospecimen Collection
  • +9 more
  • Los Angeles, California
    Yonemoto,Lisa
Jan 13, 2023

Follicular Lymphoma Trial in Worldwide (HCD122)

Completed
  • Follicular Lymphoma
  • Boston, Massachusetts
  • +11 more
Dec 6, 2020

Celiac Disease, Celiac Sprue, Gluten Enteropathy Trial in Rochester (Hu-Mik- Beta-1)

Completed
  • Celiac Disease
  • +3 more
  • Hu-Mik- Beta-1
  • Rochester, Minnesota
    Mayo Clinic, Rochester
Jan 16, 2020

Active Non Segmental Vitiligo Trial in Cairo (Narrow band ultraviolet B)

Completed
  • Active Non Segmental Vitiligo
  • Narrow band ultraviolet B
  • Cairo, Helwan, Egypt
    Nourhan Emad
Aug 8, 2022

HTLV-1 Trial run by the NINDS (Hu MiK-Beta-1)

Completed
  • HTLV-1
  • Hu MiK-Beta-1
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 26, 2019

Covid-19, Coronavirus Disease 2019 Trial in Hialeah, Winter Park, Mesquite (Bempegaldesleukin, Standard of Care, Placebo)

Completed
  • Covid-19
  • Coronavirus Disease 2019
  • Hialeah, Florida
  • +3 more
Mar 31, 2022

Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)

Completed
  • Ependymoma
  • +9 more
  • Nivolumab
  • NKTR-214
  • Little Rock, Arkansas
  • +17 more
Dec 8, 2022

Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Stereotactic body radiotherapy (SBRT)
  • +4 more
  • New York, New York
    Columbia University Irving Medical Center
Sep 15, 2023

Melanoma, Merkel Cell Carcinoma, Triple Negative Breast Cancer Trial in United States (NKTR-262, bempegaldesleukin, nivolumab)

Terminated
  • Melanoma
  • +6 more
  • Scottsdale, Arizona
  • +13 more
Jun 24, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (bempegaldesleukin, sunitinib, nivolumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Metastatic Renal Cell Carcinoma
  • bempegaldesleukin
  • +3 more
  • Anchorage, Alaska
  • +108 more
Mar 31, 2022

Parkinson's Disease (Disorder) Trial in Worldwide (IR CD-LD, IPX203 ER CD-LD, IPX203 )

Completed
  • Parkinson's Disease (Disorder)
  • IR CD-LD
  • +3 more
  • Phoenix, Arizona
  • +107 more
Jul 22, 2021

Glioblastoma Trial in New Haven (AB122, AB154, Placebo)

Recruiting
  • Glioblastoma
  • New Haven, Connecticut
    Yale University
Jul 5, 2022

T-Cell Large Granular Lymphocytic Leukemia, Leukemia, T-Cell Large Granular Lymphocytic Trial run by the NCI (Hu-MiK-Beta-1)

Completed
  • T-Cell Large Granular Lymphocytic Leukemia
  • Leukemia, T-Cell Large Granular Lymphocytic
  • Hu-MiK-Beta-1
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 10, 2019

Glioblastoma Trial (RZ-001, VGCV)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Oct 22, 2023

Labor Pain Trial in Istanbul (External pressure to the palm)

Completed
  • Labor Pain
  • External pressure to the palm
  • Istanbul, Turkey
    Istanbul University-Cerrahpasa
Oct 27, 2023

Influenza Trial in Rochester (FluBlok, Fluzone, FluCelVax)

Completed
Has Results
  • Influenza
  • FluBlok
  • +3 more
  • Rochester, New York
    University of Rochester Medical Center, Vaccine Research Unit Ro
Nov 1, 2021

Tissue Biopsy and Imaging Studies in HIV-Infected Patients

Recruiting
  • HIV
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in United States (SRF617, etrumadenant, zimberelimab)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Prostate Cancer
    • Miami, Florida
    • +6 more
    Jun 13, 2022

    Intracerebral Hemorrhage, Hypertension Trial (Mobile health intervention)

    Not yet recruiting
    • Intracerebral Hemorrhage
    • Hypertension
    • Mobile health intervention
    • (no location specified)
    Apr 13, 2023

    MDS, Graft Vs Host Disease, Graft-versus-host-disease Trial in Miami (Busulfan, Melphalan, Fludarabine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Miami, Florida
      Miami Cancer Institute
    Jan 10, 2023

    Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)

    Not yet recruiting
    • Oligometastatic Prostate Cancer
    • New York, New York
      Columbia University Irving Medical Center / NewYork-Presbyterian
    Jun 14, 2023

    Urinary Bladder Tumor, Tumor Metastasis Trial in Worldwide (Bempegaldesleukin, Nivolumab)

    Completed
    • Urinary Bladder Neoplasm
    • Neoplasm Metastasis
    • Bempegaldesleukin
    • Nivolumab
    • San Francisco, California
    • +69 more
    Jul 22, 2022

    Multiple Myeloma Trial in United States (TTI-622, Daratumumab Hyaluronidase-fihj)

    Recruiting
    • Multiple Myeloma
    • TTI-622
    • Daratumumab Hyaluronidase-fihj
    • Basking Ridge, New Jersey
    • +6 more
    Dec 8, 2022